• Primary care guidance for the prescribing and supply of Inclisiran
• Inclisiran for the treatment of familial or non-familial hyperlipidaemia in secondary prevention of CVD
• Summary of National Guidance for Lipid Management for Primary and Secondary Prevention of CVD 
• NHS South West Strategic Clinical Network - Top tips for managing AF
• Clinical guidelines for Secondary Prevention after Stroke or TIA
• Commissioning recommendations for national procurement for DOACs
  

1. The NPSA have issued advice on risks with intravenous heparin flush solutions (Rapid Response Report April 2008) in response to patient safety incident reports concerning mis-selection of sodium heparin products and reports where other medicines were mis-selected for heparin flush solution products.(www.npsa.nhs.uk/patientsafety)

2. Sodium chloride injection should be used instead of heparin to flush peripheral lines.

3. Lepirudin is used in heparin induced thrombocytopenia. Wards would normally order it through pharmacy on a named patient basis.

4. RCHT policy is as follows:
Dalteparin should be used for prophylaxis and treatment of thromboembolic disorders, treatment of unstable coronary syndrome, and treatment of pulmonary embolism.